Johnson John is a director of Axogen Inc.
Person profile
Roles
Address
Seattle, Washington
Employees
Former names
Johnson John H
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Xeris Biopharma Holdings, Inc.
1 Apr 24
4
Xeris Biopharma Holdings, Inc.
18 Mar 24
4
Verastem, Inc.
13 Mar 24
4
Axogen, Inc.
7 Sep 23
4
Xeris Biopharma Holdings, Inc.
7 Jun 23
4
Axogen, Inc.
5 Jun 23
4
Verastem, Inc.
16 May 23
4/A
Verastem, Inc.
20 Dec 22
4
Verastem, Inc.
24 Jun 22
4
Xeris Biopharma Holdings, Inc.
9 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Mar 24 | XERS Xeris Biopharma | Common Stock | Option exercise | Acquire M | No | No | 1.99 | 215,600 | 429.04 k | 751,412 |
18 Mar 24 | XERS Xeris Biopharma | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.99 | 215,600 | 429.04 k | 0 |
15 Mar 24 | XERS Xeris Biopharma | Common Stock | Other | Acquire J | No | No | 0 | 89,571 | 0.00 | 840,983 |
11 Mar 24 | VSTM Verastem | Stock Option Common Stock | Grant | Acquire A | No | No | 11.44 | 8,549 | 97.80 k | 8,549 |
11 Mar 24 | VSTM Verastem | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 49.92 | 2,083 | 103.98 k | 0 |
11 Mar 24 | VSTM Verastem | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 21.24 | 2,300 | 48.85 k | 0 |
11 Mar 24 | VSTM Verastem | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 21.72 | 2,083 | 45.24 k | 0 |
11 Mar 24 | VSTM Verastem | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 15.6 | 2,083 | 32.49 k | 0 |
1 Sep 23 | AXGN Axogen | RSU Common Stock | Grant | Acquire A | No | No | 0 | 11,904 | 0.00 | 11,904 |
1 Sep 23 | AXGN Axogen | Stock Option (right to purchase) Common Stock | Grant | Acquire A | No | No | 6.3 | 20,436 | 128.75 k | 20,436 |